Presidential hopeful Bernie Sanders criticises BioMarin’s gene therapy price

This includes  Sangamo and Pfizer, whose gene therapy achieved a dose-dependent increase in clotting Factor VIII levels across four dosage groups, each including two subjects.

The changing nature of approvals – what does the future hold?

High-profile disinvestments include those by Pfizer and Eli Lilly. However, Pfizer has since announced that, together with investment firm Bain Capital, it has created a new drug company called Cerevel

Integrating electronic health records into clinical trials

Pfizer, for example, won an expanded FDA label for breast cancer drug Ibrance on the strength of data from sources including EHRs.

Newly-listed BioNTech buys Neon to boost cell therapy assets

Mainz-based  BioNTech specialises in drugs and vaccines based on messenger RNA (mRNA) and has already secured a string of big pharma partners including deals with Pfizer, Sanofi, Roche, Eli Lilly

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]